What's new

QRD Appendix V - Adverse-drug-reaction reporting details

QRD Appendix V - Adverse-drug-reaction reporting details

Jun 10, 2025 - 15:05
 0
QRD Appendix V - Adverse-drug-reaction reporting details
Read More

Tags:

Previous Article

Minutes of the COMP meeting 14-15 April 2025

Next Article

EMEA-003395-PIP02-23

Related Posts

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Date of authorisation: 01/12/2008, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0